For more than two decades, CD4 cell count measurements have been central to
understanding HIV disease progression, making important clinical decisions, and monitoring …

Co-trimoxazole is an inexpensive, broad-spectrum antimicrobial drug that is widely used in
developing countries. Before antiretroviral therapy (ART) scale-up, co-trimoxazole …

Abstract The American Thoracic Society, Centers for Disease Control and Prevention, and
Infectious Diseases Society of America jointly sponsored the development of this guideline …

Background Co-trimoxazole (fixed-dose trimethoprim–sulfamethoxazole) prophylaxis
administered before antiretroviral therapy (ART) reduces morbidity in children infected with …

Background Today's uncertain HIV funding landscape threatens to slow progress towards
treatment goals. Understanding the costs of antiretroviral therapy (ART) will be essential for …

Rationale: There is evidence suggesting that birth weight may influence lung function in
adulthood, but it is unclear whether it might differentially affect restrictive (FVC) and …

Introduction Co-trimoxazole prophylaxis is used to reduce morbidity and mortality in people
with HIV. We systematically reviewed three topics related to co-trimoxazole prophylaxis to …

Objective: Untreated advanced HIV infection alters the gut microbiota, but it is unclear
whether antiretroviral therapy (ART) reverses these changes. We compared the composition …

Introduction: Tuberculosis is a public health problem in Nigeria. One of the most effective
ways of controlling tuberculosis is the directly observed treatment short-course. However …

Objective To evaluate the rates, timing and determinants of default and death among adult
tuberculosis patients in Nigeria. Methods Routine surveillance data were used. A …